Oramed Pharmaceuticals Inc. (ORMP)
Oxford Ledge is still expanding full research coverage of ORMP. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A pharmaceutical company developing oral protein delivery technology while making strategic investments in healthcare companies.
SEC filings
- 8-K Amendments to articles or bylaws; Other material event; Financial statements and exhibits 2026-06-30
- 10-Q Quarterly financial report (unaudited) 2026-05-19
- 8-K Entry into material agreement; Completion of acquisition or disposition 2026-03-31
- 10-K Annual financial report with audited statements 2026-03-26
- 8-K Entry into material agreement; Financial statements and exhibits 2026-02-20
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for ORMP. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open ORMP in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.